USANA Health Sciences Stock Price, News & Analysis (NYSE:USNA) $47.26 +0.56 (+1.20%) (As of 11/30/2023 ET) Add Compare Share Share Today's Range$46.06▼$47.4050-Day Range$44.45▼$60.4052-Week Range$44.01▼$69.60Volume73,987 shsAverage Volume69,205 shsMarket Capitalization$904.08 millionP/E Ratio15.29Dividend YieldN/APrice Target$53.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability USANA Health Sciences MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside12.1% Upside$53.00 Price TargetShort InterestHealthy1.66% of Float Sold ShortDividend StrengthN/ASustainability-1.96Upright™ Environmental ScoreNews SentimentN/AInsider TradingSelling Shares$22,545 Sold Last QuarterProj. Earnings Growth-1.02%From $2.94 to $2.91 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.79 out of 5 starsMedical Sector775th out of 948 stocksMedicinals & Botanicals Industry6th out of 12 stocks 2.3 Analyst's Opinion Consensus RatingUSANA Health Sciences has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $53.00, USANA Health Sciences has a forecasted upside of 12.1% from its current price of $47.26.Amount of Analyst CoverageUSANA Health Sciences has only been the subject of 1 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted1.66% of the float of USANA Health Sciences has been sold short.Short Interest Ratio / Days to CoverUSANA Health Sciences has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in USANA Health Sciences has recently decreased by 2.68%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldUSANA Health Sciences does not currently pay a dividend.Dividend GrowthUSANA Health Sciences does not have a long track record of dividend growth. Previous Next 3.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreUSANA Health Sciences has received a 27.07% net impact score from Upright. The largest positive contribution comes from its "Nutrition" impact, which is mostly driven by its "Direct selling of nutritional products through representatives", "Direct selling of dietary supplements through representatives", and "Direct selling of skincare products through representatives" products. See details.Environmental SustainabilityThe Environmental Impact score for USANA Health Sciences is -1.96. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for USANA Health Sciences this week, compared to 2 articles on an average week. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, USANA Health Sciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $22,545.00 in company stock.Percentage Held by InsidersOnly 0.33% of the stock of USANA Health Sciences is held by insiders.Percentage Held by Institutions52.62% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for USANA Health Sciences are expected to decrease by -1.02% in the coming year, from $2.94 to $2.91 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of USANA Health Sciences is 15.29, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 112.12.Price to Earnings Ratio vs. SectorThe P/E ratio of USANA Health Sciences is 15.29, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 109.90.Price to Earnings Growth RatioUSANA Health Sciences has a PEG Ratio of 1.31. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioUSANA Health Sciences has a P/B Ratio of 1.92. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About USANA Health Sciences Stock (NYSE:USNA)USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.Read More USNA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart USNA Stock News HeadlinesNovember 29, 2023 | americanbankingnews.comUSANA Health Sciences (NYSE:USNA) Downgraded by StockNews.com to "Buy"November 22, 2023 | americanbankingnews.comUSANA Health Sciences (NYSE:USNA) Raised to Strong-Buy at StockNews.comDecember 1, 2023 | Tomorrow Investor (Ad)The Only Practical Solution to the World’s Looming Energy CrisisThere’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!November 20, 2023 | finance.yahoo.comUSANA Health Sciences (NYSE:USNA) investors are sitting on a loss of 62% if they invested five years agoNovember 1, 2023 | finance.yahoo.comKevin Guest Says Emotional Intelligence is a Game Changer in Business SuccessOctober 26, 2023 | finance.yahoo.comUSANA Health Sciences, Inc. (NYSE:USNA) Q3 2023 Earnings Call TranscriptOctober 26, 2023 | finance.yahoo.comQ3 2023 USANA Health Sciences Inc Earnings CallOctober 24, 2023 | markets.businessinsider.comUSANA Health Sciences Reports Decline In Q3 Income, misses estimatesDecember 1, 2023 | Tomorrow Investor (Ad)The Only Practical Solution to the World’s Looming Energy CrisisThere’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!October 24, 2023 | finance.yahoo.comUSANA Health Sciences Reports Third Quarter 2023 ResultsOctober 24, 2023 | finance.yahoo.comUSANA Health Sciences (USNA) Q3 Earnings Miss EstimatesOctober 24, 2023 | finance.yahoo.comUsana Health Sciences Inc (USNA) Reports Q3 2023 Earnings: Net Sales Down 9% Year-Over-YearOctober 23, 2023 | benzinga.comUsana Health Sciences's Earnings: A PreviewOctober 23, 2023 | msn.comUSANA Health Sciences Q3 2023 Earnings PreviewOctober 23, 2023 | seekingalpha.comUSANA: New Digital Tools And Solid Balance Sheet Imply UndervaluationOctober 19, 2023 | finance.yahoo.comPTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?October 18, 2023 | finance.yahoo.comUSANA Joins the USA Bobsled/Skeleton Family as Official Supplement SupplierOctober 17, 2023 | finance.yahoo.comEarnings Preview: USANA Health Sciences (USNA) Q3 Earnings Expected to DeclineOctober 16, 2023 | finance.yahoo.comUSANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate CapitalOctober 11, 2023 | finance.yahoo.comUSNA or STVN: Which Is the Better Value Stock Right Now?October 2, 2023 | finance.yahoo.comKevin Guest Shares 5 Benefits of Returning to OfficeSeptember 13, 2023 | finance.yahoo.comUSNA vs. ZTS: Which Stock Is the Better Value Option?September 6, 2023 | finance.yahoo.comUSANA Philippines Awarded for Corporate and Human Resource ExcellenceSeptember 6, 2023 | finance.yahoo.comJoin USANA for September #HungerActionMonth to Fight to End HungerAugust 16, 2023 | finance.yahoo.comUSANA HR Professional Recognized for ExcellenceAugust 14, 2023 | finance.yahoo.comUSANA continues its industry-leading scientific innovation by announcing three new products at Americas & Europe ConventionAugust 13, 2023 | finance.yahoo.comUSANA Health Sciences, Inc.'s (NYSE:USNA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?See More Headlines Receive USNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/24/2023Today11/30/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/06/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Medicinals & botanicals Sub-IndustryPersonal Products SectorMedical Current SymbolNYSE:USNA CUSIP90328M10 CIK896264 Webwww.usana.com Phone(801) 954-7100Fax801-954-7300Employees1,900Year FoundedN/APrice Target and Rating Average Stock Price Target$53.00 High Stock Price Target$53.00 Low Stock Price Target$53.00 Potential Upside/Downside+12.7%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$3.09 Trailing P/E Ratio15.22 Forward P/E Ratio16.00 P/E Growth1.31Net Income$69.35 million Net Margins6.45% Pretax Margin10.63% Return on Equity13.08% Return on Assets9.94% Debt Debt-to-Equity RatioN/A Current Ratio3.47 Quick Ratio2.94 Sales & Book Value Annual Sales$998.60 million Price / Sales0.90 Cash Flow$4.79 per share Price / Cash Flow9.81 Book Value$24.59 per share Price / Book1.91Miscellaneous Outstanding Shares19,130,000Free Float19,067,000Market Cap$899.68 million OptionableOptionable Beta0.82 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Kevin G. Guest (Age 60)Executive Chairman Comp: $1.29MMr. Jim Brown (Age 54)CEO & President Comp: $790.56kMr. G. Douglas Hekking (Age 53)Chief Financial Officer Comp: $648.81kMr. Walter Noot (Age 57)Chief Operating Officer Comp: $624.56kMr. David Mulham (Age 63)Chief Sales Officer Comp: $601.72kDr. Myron W. Wentz (Age 82)Founder & Chairman Emeritus Dr. John CuomoExecutive Director of Product Development & TechnologyDr. Robert A. Sinnott M.N.S. (Age 58)Ph.D., Chief Scientific Officer Mr. Patrique RichardsExecutive Director of Investor Relations & Business DevelopmentMr. P. Joshua Foukas (Age 47)Chief Legal Officer, General Counsel & Corporate Secretary More ExecutivesKey CompetitorsCronos GroupNASDAQ:CRONCanopy GrowthNASDAQ:CGCbioteNASDAQ:BTMDKeros TherapeuticsNASDAQ:KROSParagon 28NYSE:FNAView All CompetitorsInsiders & InstitutionsAmerican Century Companies Inc.Bought 3,028 shares on 11/30/2023Ownership: 0.711%Deutsche Bank AGSold 26,772 shares on 11/24/2023Ownership: 0.035%Public Sector Pension Investment BoardSold 6,030 shares on 11/22/2023Ownership: 0.072%Comerica BankBought 5,393 shares on 11/21/2023Ownership: 0.028%Jacobs Levy Equity Management Inc.Bought 2,168 shares on 11/17/2023Ownership: 0.474%View All Insider TransactionsView All Institutional Transactions USNA Stock Analysis - Frequently Asked Questions Should I buy or sell USANA Health Sciences stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" USNA shares. View USNA analyst ratings or view top-rated stocks. What is USANA Health Sciences' stock price target for 2024? 2 Wall Street analysts have issued twelve-month price targets for USANA Health Sciences' shares. Their USNA share price targets range from $53.00 to $53.00. On average, they anticipate the company's share price to reach $53.00 in the next year. This suggests a possible upside of 12.1% from the stock's current price. View analysts price targets for USNA or view top-rated stocks among Wall Street analysts. How have USNA shares performed in 2023? USANA Health Sciences' stock was trading at $53.20 on January 1st, 2023. Since then, USNA shares have decreased by 11.2% and is now trading at $47.26. View the best growth stocks for 2023 here. When is USANA Health Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 6th 2024. View our USNA earnings forecast. How were USANA Health Sciences' earnings last quarter? USANA Health Sciences, Inc. (NYSE:USNA) issued its earnings results on Tuesday, October, 24th. The company reported $0.59 EPS for the quarter, missing analysts' consensus estimates of $0.64 by $0.05. The firm had revenue of $213.37 million for the quarter, compared to the consensus estimate of $212.24 million. USANA Health Sciences had a net margin of 6.45% and a trailing twelve-month return on equity of 13.08%. What ETFs hold USANA Health Sciences' stock? ETFs with the largest weight of USANA Health Sciences (NYSE:USNA) stock in their portfolio include Invesco S&P SmallCap Consumer Staples ETF (PSCC), Roundhill Acquirers Deep Value ETF (DEEP), Global X Health & Wellness ETF (BFIT), ETC 6 Meridian Low Beta Equity Strategy ETF (SIXL), What guidance has USANA Health Sciences issued on next quarter's earnings? USANA Health Sciences updated its FY23 earnings guidance on Tuesday, October, 24th. The company provided earnings per share (EPS) guidance of $2.80-3.05 for the period, compared to the consensus estimate of $3.13. The company issued revenue guidance of $900-920 million, compared to the consensus revenue estimate of $930.04 million. What is Kevin Guest's approval rating as USANA Health Sciences' CEO? 68 employees have rated USANA Health Sciences Chief Executive Officer Kevin Guest on Glassdoor.com. Kevin Guest has an approval rating of 99% among the company's employees. This puts Kevin Guest in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of USANA Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other USANA Health Sciences investors own include International Business Machines (IBM), Gilead Sciences (GILD), NVIDIA (NVDA), AT&T (T), BioMarin Pharmaceutical (BMRN), Vertex Pharmaceuticals (VRTX), AbbVie (ABBV), Walt Disney (DIS), Intuitive Surgical (ISRG) and Johnson & Johnson (JNJ). Who are USANA Health Sciences' major shareholders? USANA Health Sciences' stock is owned by many different retail and institutional investors. Top institutional investors include Pzena Investment Management LLC (4.08%), Charles Schwab Investment Management Inc. (1.11%), Acadian Asset Management LLC (0.90%), American Century Companies Inc. (0.71%), Invesco Ltd. (0.64%) and Bank of New York Mellon Corp (0.60%). Insiders that own company stock include Brent Neidig, Daniel A Macuga, Daniel A Macuga, David Mulham Mulham, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Gilbert A Fuller, Jim Brown, John Turman Fleming, Joshua Foukas, Kevin Guest, Paul A Jones, Robert A Sinnott, Robert Auciaux, Timothy E Wood, Walter Noot and Xia Ding. View institutional ownership trends. How do I buy shares of USANA Health Sciences? Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NYSE:USNA) was last updated on 12/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding USANA Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.